2023-08-10 06:46:29 ET
- DarioHealth press release ( NASDAQ: DRIO ): Q2 GAAP EPS of -$0.58 misses by $0.06 .
- Revenue of $6.15M (-0.5% Y/Y) beats by $0.14M .
- Cash and cash equivalents balance as of the end of the second quarter of 2023 of $52.6 million, which provides estimated runway through 2025.
- Non-GAAP billings for the three months ended June 30, 2023, were $6.0 million, a 1.2% decrease from $6.09 million for the three months ended June 30, 2022.
- "Our proforma gross margins increased to 51.5% in the second quarter of 2023, up significantly from 36.1% in the second quarter of 2022, while reducing our operating expense run rate by 13% over that period."
For further details see:
DarioHealth GAAP EPS of -$0.58 misses by $0.06, revenue of $6.15M beats by $0.14M